Provided by Tiger Fintech (Singapore) Pte. Ltd.

Psyence Biomedical Ltd

0.6900
-0.0010-0.14%
Volume:37.04K
Turnover:25.72K
Market Cap:3.12M
PE:0.00
High:0.7115
Open:0.6910
Low:0.6800
Close:0.6910
Loading ...

Republicans spending package includes no PBM reform, Punchbowl says

TIPRANKS
·
20 Dec 2024

PBM reform looks manageable for CVS Health, says UBS

TipRanks
·
19 Dec 2024

S&P 500 Gains and Losses Today: Index Drops as Fed Cuts Rates but Signals Caution

Investopedia
·
19 Dec 2024

S&P 500 Gains and Losses Today: Health Care Stocks Fall as Trump Eyes 'Middlemen'

Investopedia
·
18 Dec 2024

Psyence Biomedical highlights progress on Phase IIb clinical trial

TIPRANKS
·
17 Dec 2024

Psyence Biomed Highlights Recent Progress on Active Phase Iib Clinical Trial

THOMSON REUTERS
·
17 Dec 2024

S&P 500 Gains and Losses Today: Tesla Stock Boosted by AI, Self-Driving Optimism

Investopedia
·
17 Dec 2024

CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst

Blockhead
·
13 Dec 2024

S&P 500 Gains and Losses Today: Broadcom Soars on Reports of Apple AI Chip Tie-Up

Investopedia
·
12 Dec 2024

New PBM Legislation Sparks Healthcare Selloff on Wall Street -- Barrons.com

Dow Jones
·
12 Dec 2024

CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up? -- Barrons.com

Dow Jones
·
12 Dec 2024

Psyence Biomedical executes binding agreements with Optimi Health

TipRanks
·
11 Dec 2024

Why Walgreens Boots Alliance Soared Today

Motley Fool
·
11 Dec 2024

BRIEF-Psyence Biomed Executes Agreements With Optimi Health

Reuters
·
10 Dec 2024

Psyence Biomedical Ltd - Optimi to Provide Cmc Support for Psyence's Clinical Trials

THOMSON REUTERS
·
10 Dec 2024

Psyence Biomedical Ltd - Will Obtain Exclusive Rights to Optimi's Drug Candidate for Treatment Use in Palliative Care Context

THOMSON REUTERS
·
10 Dec 2024